Initially approved in 2012, linaclotide is already indicated for treating chronic idiopathic constipation and IBS-C in adults ...
The FDA has approved Linzess (linaclotide) for children aged 7 and older with IBS-C, marking the first FDA-approved drug for ...
The FDA expands use of linaclotide to children as young as age 7 years with irritable bowel syndrome with constipation (IBS-C ...
The new approval that came from the USFDA makes it sure that the Linzess is safe and effective, bringing a sense of relief ...
Around a third of children in the UK will experience some form of constipation - but what is it, and how can you help?